Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H15NO.ClH |
| Molecular Weight | 213.704 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(N(C)C)C(=O)C1=CC=CC=C1
InChI
InChIKey=APOWZIQNQJSLKG-UHFFFAOYSA-N
InChI=1S/C11H15NO.ClH/c1-9(12(2)3)11(13)10-7-5-4-6-8-10;/h4-9H,1-3H3;1H
| Molecular Formula | C11H15NO |
| Molecular Weight | 177.2429 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Metamfepramone (dimethylcathinone, dimethylpropion, and dimepropion) was synthesized by various routes in the 1930s and 1940s and clinically evaluated as anorectic as well as a treatment of hypotension and symptoms
of the common cold. It was widely used for the treatment of the common cold or hypotonic conditions. Due to its stimulating properties and its rapid metabolism resulting in major degradation products such as methylpseudoephedrine and methcathinone, it has been considered relevant for doping controls by the World Anti-Doping Agency (WADA). Metamfepramone was marketed as an appetite suppressant, but was made illegal in 2006.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry. | 2009 |
|
| Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or lesions of the nucleus basalis of Meynert. | 2004-02-19 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19661559
One capsule (accounting for a total of 10mg
of metamfepramone-HCl), was orally ingested
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:42 GMT 2025
by
admin
on
Mon Mar 31 18:12:42 GMT 2025
|
| Record UNII |
6Y816E97O1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000085922
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY | |||
|
233-289-9
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY | |||
|
DTXSID00905920
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY | |||
|
SUB03185MIG
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY | |||
|
6Y816E97O1
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY | |||
|
3084061
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY | |||
|
10105-90-5
Created by
admin on Mon Mar 31 18:12:42 GMT 2025 , Edited by admin on Mon Mar 31 18:12:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |